Bill of Health

OCTOBER 31, 2022

Some COVID-19 vaccine manufacturers in the US have refused to share vaccine samples for research purposes , creating an access issue with the potential to delay comparator studies, follow-on research, and new vaccine / drug development. By Aparajita Lath. This problem is not new in the biotechnology sector.

COVID-19 174

COVID-19 COVID-19 Vaccine Licensing FDA 174

HIT Consultant

AUGUST 18, 2021

The world has been in urgent need of COVID-19 vaccines, treatments, and diagnostic tools. Social distancing and occupancy restrictions have expedited the digital transformation of clinical trial study design and execution as industry players have raced toward COVID-19 vaccine and treatment development.

COVID-19 52

COVID-19 COVID-19 Vaccine Pharmaceutical Industry FDA 52

Bill of Health

AUGUST 29, 2022

Despite pediatric COVID-19 vaccine availability, many youth remain unvaccinated , and are thus at higher risk of life-altering outcomes as a result of contracting COVID-19. [1]. Specific to the COVID-19 vaccine, children under age 18 in most jurisdictions will require parental consent. [8].

COVID-19 Vaccine 130

COVID-19 Vaccine COVID-19 Informed Consent Governance 130

Drug & Device Law

JANUARY 4, 2024

The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19 vaccine that was used to control the recent pandemic. The FDA, however, did not and does not share that belief. FDA (8/23/21) press release (emphasis original). Again, the FDA does not agree.

COVID-19 Vaccine 59

COVID-19 Vaccine COVID-19 FDA Public Health 59